Multiple myeloma, including Hilmo

C3_MULT_MYELOMA_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C90.0 Hospital discharge: ICD-9 — 2030A Cause of death: ICD-10 — C90.0 Cause of death: ICD-9 — 2030A Cancer registry: Topography ICD-O-3 — ANY Cancer registry: Morphology ICD-O-3 — 9732 Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	2799
4. Check minimum number of events None	2799
5. Include endpoints None	2799
6. Filter based on genotype QC (FinnGen only)	1767

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_MULT_MYELOMA_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C900
HD_ICD_9	2030A
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C900
COD_ICD_9	2030A
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	ANY
CANC_TOPO_EXCL
CANC_MORPH	9732
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Multiple myeloma, including Hilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1767	775	992
Unadjusted period prevalence (%)	0.38	0.28	0.45
Median age at first event (years)	70.07	68.96	70.94

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1831: Matched controls
18310

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

64.4

316.2

175

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

415.9

315.0

308

C90.0

ICD-10 Finland

Multiple myeloma

+∞

307.7

1701

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

22.6

307.7

301

158

AA1AA

NOMESCO Finland

Head X-ray examination

59.5

307.7

261

ZX112

NOMESCO Finland

Subcutaneous

99.1

307.7

299

JN4AD

NOMESCO Finland

Body CT examination

9.5

307.7

464

632

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

176.4

307.7

161

WF049

NOMESCO Finland

Radiotherapy of metastasis

1963.8

307.7

317

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

+∞

307.7

1067

153

Kela drug reimbursment

Lenalidomid

+∞

307.7

830

WW500

NOMESCO Finland

Blood transfusion

28.8

307.7

327

137

329

Kela drug reimbursment

Lenalidomide

+∞

307.7

634

ZX120

NOMESCO Finland

Intravenous

9.4

307.7

465

640

L04AX04

ATC

lenalidomide; oral

+∞

307.7

797

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

14.5

307.7

474

432

L03AA02

ATC

filgrastim; parenteral

2053.4

307.7

568

B03XA02

ATC

darbepoetin alfa; parenteral

32.0

307.7

301

112

N02AA05

ATC

oxycodone; systemic

7.4

307.7

852

1934

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

6.3

307.7

1214

4344

XW000

NOMESCO Finland

Bone marrow biopsy

78.4

307.7

883

215

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2806.7

307.7

1301

M04AA01

ATC

allopurinol; systemic

8.9

307.7

909

1832

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

51.7

307.7

359

J05AB01

ATC

aciclovir; systemic

7.8

307.7

985

2389

A04AA01

ATC

ondansetron; systemic, rectal

49.7

307.7

657

204

H02AB02

ATC

dexamethasone; systemic

279.9

307.7

1118

102

WW300

NOMESCO Finland

Transfer of autologic stem cells

3226.8

304.7

286

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

15.8

304.0

276

203

WX2DD

NOMESCO Finland

Low-dose CT of skeleton in whole body

847.5

300.0

287

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

1075.8

288.5

275

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

2745.0

265.1

250

ZX108

NOMESCO Finland

Inhalation

58.7

259.6

146

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

8.8

254.2

357

491

Z51.5

ICD-10 Finland

Palliative care

8.8

251.9

352

481

L01AA03

ATC

melphalan; systemic

+∞

247.7

232

B03XA01

ATC

erythropoietin; parenteral

45.9

243.0

144

393

Kela drug reimbursment

Pomalidomide

+∞

230.2

216

R50.9

ICD-10 Finland

Fever, unspecified

5.4

229.9

587

1464

A49.9

ICD-10 Finland

Bacterial infection, unspecified

5.7

227.3

536

1246

L04AX06

ATC

pomalidomide; oral

+∞

220.4

207

A03FA01

ATC

metoclopramide; systemic, rectal

5.7

220.1

502

1130

1507

Kela drug reimbursment

Pomalidomide

+∞

218.2

205

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2159.9

214.8

204

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

12.0

213.3

227

214

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

576.9

211.5

206

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

50.8

205.8

119

XX3DW

NOMESCO Finland

Time consuming IT work

8.4

202.6

287

395

J05AB11

ATC

valaciclovir; oral

4.9

189.9

535

1426

212

Kela drug reimbursment

Gout

11.9

189.4

201

188

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

2107.8

188.8

180

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

9.8

186.8

230

265

WF002

NOMESCO Finland

Radical radiotherapy

80.4

185.6

M05BX04

ATC

denosumab; parenteral

6.6

175.4

316

562

WZC00

NOMESCO Finland

Treatment plan or consultation

3.8

166.2

826

3277

JN4BD

NOMESCO Finland

Extensive body CT

7.3

165.6

263

409

B01AB05

ATC

enoxaparin; parenteral

3.7

164.3

877

3640

L01AA01

ATC

cyclophosphamide; systemic

63.0

162.3

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

1653.9

155.5

149

M05BA02

ATC

clodronic acid; systemic

1556.8

148.0

142

WW200

NOMESCO Finland

Immunization

10.8

147.3

165

166

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

506.1

143.5

141

B01AB10

ATC

tinzaparin; parenteral

5.1

143.4

351

820

WF004

NOMESCO Finland

Palliative radiotherapy

1461.5

140.5

135

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

33.8

140.5

WW409

NOMESCO Finland

Other aferesis

+∞

140.4

133

M90.7*C90.0

ICD-10 Finland

Pathological fracture in multiple myeloma

+∞

138.3

131

YNB10

NOMESCO Finland

Collection of stem cells for transplant

+∞

136.2

129

C61

ICD-10 Finland

Malignant neoplasm of prostate

287.1

132.1

133

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

4.3

131.5

406

1135

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

128.7

122

NE1AA

NOMESCO Finland

Pelvis X-ray examination

4.5

127.4

364

958

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.3

127.0

1226

6956

J01MA12

ATC

levofloxacin; systemic

3.5

124.6

570

2081

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

124.4

118

L01FC01

ATC

daratumumab; parenteral

+∞

116.9

111

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

57.0

116.8

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

314.2

116.6

117

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

8.0

115.0

163

221

D64.9

ICD-10 Finland

Anaemia, unspecified

3.7

114.3

451

1487

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

113.7

108

C90.2

ICD-10 Finland

Extramedullary plasmacytoma

+∞

113.7

108

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

21.2

112.3

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

+∞

111.6

106

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.9

111.2

394

1206

L03AA13

ATC

pegfilgrastim; parenteral

571.2

110.0

108

D70.89

ICD-10 Finland

Neutropenic splenomegaly

23.5

109.1

B74

ICPC

Malignant neoplasm blood other

1112.0

108.6

105

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.9

103.8

822

4043

1XX32, ,

NOMESCO Finland

+∞

103.1

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

102.0

398

Kela drug reimbursment

Ixazomib

+∞

102.0

130

Kela drug reimbursment

Malignant tumour

+∞

98.9

A04AA02

ATC

granisetron; systemic, transdermal

179.9

98.3

102

3060, ,

Kela drug reimbursment

+∞

97.8

E83.50

ICD-10 Finland

Hypercalcemia

12.4

97.6

5BA08, ,

NOMESCO Finland

26.7

97.1

1505

Kela drug reimbursment

Ixazomib

+∞

96.7

1534, ,

Kela drug reimbursment

+∞

96.7

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

45.2

96.1

E85.9

ICD-10 Finland

Amyloidosis, unspecified

48.1

95.7

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.0

95.3

556

2299

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

6.1

94.0

172

305

GA5AA

NOMESCO Finland

Rib X-ray examination

35.8

93.8

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

8.6

90.1

118

145

L04AX02

ATC

thalidomide; oral

900.5

88.5

127

Kela drug reimbursment

Transplant complication

14.1

87.4

TK800

NOMESCO Finland

Hemodialysis

8.5

86.9

115

143

M84.4

ICD-10 Finland

Pathological fracture, not elsewhere classified

51.4

86.6

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

6.8

86.2

141

223

L02AE02

ATC

leuprorelin; implant, parenteral

41.1

85.7

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

14.2

84.8

J01MA14

ATC

moxifloxacin; systemic

3.8

84.7

294

877

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

4.1

83.6

252

680

115

Kela drug reimbursment

Breast cancer

+∞

82.9

C03CA01

ATC

furosemide; systemic

2.5

81.1

947

5459

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

80.8

M49.5*C90.0

ICD-10 Finland

Vertebral fracture due to multiple myeloma

+∞

79.8

116

Kela drug reimbursment

Prostate cancer

+∞

79.8

WW402

NOMESCO Finland

Leucoferesis

+∞

78.7

A02BC02

ATC

pantoprazole; systemic

2.9

78.7

1423

10031

D70.82

ICD-10 Finland

Drug-induced neutropenia

34.2

78.4

ZX090

NOMESCO Finland

Other technic of radiotherapy

143.0

77.6

WVA30

NOMESCO Finland

Intramuscular and subcutaneous injection

40.2

77.0

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

167.2

76.7

N17.9

ICD-10 Finland

Acute renal failure, unspecified

4.5

76.4

203

497

A79

ICPC

Malignancy NOS

203.5

75.8

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

5.5

74.5

151

294

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

72.4

539

2485

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

4.2

69.2

202

530

PJA12

NOMESCO Finland

Sentinel node biopsy

693.4

68.5

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

149.8

68.4

WVA20

NOMESCO Finland

Medicine administration

6.3

67.6

118

199

Z52.89

ICD-10 Finland

Donor of other organ or tissue

+∞

66.0

A06AH03

ATC

naloxegol; oral

19.1

65.8

JN4CD

NOMESCO Finland

Very extensive body CT

8.8

65.6

100

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

650.3

64.3

A05AA02

ATC

ursodeoxycholic acid; oral

10.1

63.7

H02AB09

ATC

hydrocortisone; systemic

7.1

61.4

138

L01XG03

ATC

ixazomib; oral

+∞

59.7

WX1BG

NOMESCO Finland

Total body MRI with high intensity magnet

312.4

59.7

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

9.9

59.5

A41.9

ICD-10 Finland

Sepsis, unspecified

4.6

59.4

150

351

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

58.7

C90

ICD-10 Finland

Multiple myeloma and malignant plasma cell neoplasms

+∞

57.6

NF3AA

NOMESCO Finland

Femur X-ray examination

5.8

57.6

108

195

WZC30

NOMESCO Finland

Teaching

2.8

57.3

335

1350

GD1AD

NOMESCO Finland

Thorax CT examination

3.8

57.1

190

545

TPX10

NOMESCO Finland

Implantation of vascular injection port

6.9

56.8

134

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

+∞

56.5

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

290.1

55.5

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.8

55.3

315

1250

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.5

55.1

203

623

WF003

NOMESCO Finland

Adjuvant radiotherapy

554.1

54.8

HAB40

NOMESCO Finland

Wedge excision of mammary gland

22.7

54.5

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

54.4

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

54.4

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.1

53.9

806

4906

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

543.5

53.8

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

53.4

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

4.8

52.9

124

273

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

532.9

52.8

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

12.1

52.5

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

51.3

A06AD11

ATC

lactulose; oral

2.4

50.5

427

2047

H02AB06

ATC

prednisolone; systemic

2.1

50.0

978

6525

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

11.1

48.8

L02BG04

ATC

letrozole; oral

64.1

48.5

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

48.1

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

91.0

48.1

NB6AA

NOMESCO Finland

Humerus X-ray examination

5.2

47.3

101

205

HA1AA

NOMESCO Finland

X-ray mammography

4.9

47.2

106

225

C90.1

ICD-10 Finland

Plasma cell leukaemia

+∞

47.1

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

6.1

46.3

140

WZC15, ,

NOMESCO Finland

125.8

46.0

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

45.0

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

3.7

44.7

152

441

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

43.9

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

+∞

43.9

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.5

43.0

303

1327

N08.1*C90.0

ICD-10 Finland

Glomerular disorders in multiple myeloma

+∞

42.9

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

+∞

42.9

N02AX02

ATC

tramadol; systemic, rectal

2.0

42.7

862

5707

L01XX50

ATC

[U] ixazomib

+∞

41.8

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.5

41.8

105

244

N17.8

ICD-10 Finland

Other acute renal failure

6.8

41.8

100

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.9

41.8

129

350

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

40.8

N03AX16

ATC

[U] pregabalin

2.1

40.2

488

2684

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.9

40.2

917

6284

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

+∞

39.7

E85.89

ICD-10 Finland

Other amyloidosis

88.1

38.9

N05CF01

ATC

zopiclone; oral

2.0

38.9

684

4286

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

4.4

38.5

230

Y77

ICPC

Malignant neoplasm prostate

136.2

37.9

N16.1*C90.0

ICD-10 Finland

Renal tubulo-interstitial disorders in multiple myeloma

+∞

37.6

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

6.8

37.5

JN6AD

NOMESCO Finland

CT of torso and neck

10.5

37.0

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.9

36.9

190

707

ZX070

NOMESCO Finland

Intensity modified radiotherapy

132.8

36.8

A11CC03

ATC

alfacalcidol; systemic

4.7

36.7

189

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.7

36.2

187

L02BA01

ATC

tamoxifen; oral

364.3

36.1

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

12.2

36.0

NB4AA

NOMESCO Finland

Scapula X-ray examination

14.0

35.7

L02BB03

ATC

bicalutamide; oral

+∞

35.5

HAC20

NOMESCO Finland

Total mastectomy

125.8

34.8

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

8.3

34.7

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

+∞

34.5

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.9

34.4

106

287

Z3231

NOMESCO Finland

Registered nurse

2.0

34.0

523

3105

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

33.4

Z51.0

ICD-10 Finland

Radiotherapy session

332.9

33.0

ZXD05

NOMESCO Finland

Urgent procedure

1.9

32.7

582

3619

NFJ60

NOMESCO Finland

Internal fixation of fracture of other parts of femur with intramedullary nail

9.7

32.5

L03AB05

ATC

interferon alfa-2b; parenteral

+∞

32.4

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

11.6

31.9

N18.8

ICD-10 Finland

Other chronic renal failure

4.0

31.7

243

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

10.5

31.6

KA1AE

NOMESCO Finland

Kidney ultrasound examination

4.7

31.5

163

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.5

31.4

216

928

L04AD01

ATC

ciclosporin; systemic

6.2

31.1

C50.99

ICD-10 Finland

Breast, unspecified

318.1

30.9

1CX01, ,

NOMESCO Finland

112.0

30.7

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

9.9

30.4

EBA10

NOMESCO Finland

Operative extraction of tooth

2.6

30.3

196

818

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

30.3

2030A

ICD-9 Finland

Multiple myeloma and immunoproliferative neoplasms, Multiple myeloma

+∞

30.3

ZZR00

NOMESCO Finland

Flap of skin

11.2

30.3

NK6AN

NOMESCO Finland

Total body bone isotope imaging

29.2

29.9

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.6

29.7

183

745

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

157.6

29.7

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

7.5

29.3

L01BC06

ATC

capecitabine; oral

+∞

29.2

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.3

29.2

253

1204

NA2AD

NOMESCO Finland

Thoracic spine CT examination

8.9

29.0

306

Kela drug reimbursment

Erythropoietin and darbepoetin

49.4

28.5

9731/3-C42.1

ICD-O-3

Plasmacytoma, NOS, of bone marrow

+∞

28.2

JN3AD

NOMESCO Finland

Abdominal CT examination

2.2

28.1

258

1256

I43.1*E85.9

ICD-10 Finland

Cardiac amyloidosis

39.6

28.1

SAA03

NOMESCO Finland

Extended examination of mouth

1.8

28.0

635

4210

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

65.1

28.0

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.7

27.9

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

27.9

685

4647

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

27.5

601

3939

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

27.4

488

3005

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

4.3

27.4

169

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.9

27.2

138

508

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

27.1

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

27.1

WX1CG

NOMESCO Finland

Extensive total body MRI with high intensity magnet

+∞

27.1

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

26.9

552

3547

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

6.6

26.9

NBJ60

NOMESCO Finland

Internal fixation of fracture of shoulder or upper arm using intramedullary nail, humerus

41.9

26.8

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

7.4

26.3

M90.7

ICD-10 Finland

Fracture of bone in neoplastic disease

+∞

26.1

A04AA55

ATC

palonosetron, combinations; systemic

+∞

26.1

WD335, ,

NOMESCO Finland

+∞

26.1

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

5.3

26.1

103

WF099

NOMESCO Finland

Other radiotherapy

40.7

25.9

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

264.2

25.8

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

5.0

25.7

112

A07AA02

ATC

nystatin; oral

2.7

25.5

143

555

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.2

25.1

229

1109

WX1DG

NOMESCO Finland

Very extensive total body MRI with high intensity magnet

+∞

25.1

ZX112, ,

SPAT

9.8

25.0

ZXE00

NOMESCO Finland

One hour or less

1.7

24.9

656

4505

D75.9

ICD-10 Finland

Disease of blood and blood-forming organs, unspecified

23.8

24.8

N19

ICD-10 Finland

Unspecified kidney failure

2.8

24.7

126

465

ECB20

NOMESCO Finland

Oral alveoplasty

6.6

24.3

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

29.6

24.1

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

3.4

24.0

278

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

3.9

23.9

183

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

8.7

23.7

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.1

23.4

100

334

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

4.7

23.0

115

YX9AW, ,

NOMESCO Finland

+∞

23.0

5BA03, ,

NOMESCO Finland

+∞

23.0

WW302

NOMESCO Finland

Allogenic transfer of stem cells from relative

+∞

23.0

M49.5*C79.5

ICD-10 Finland

Metastatic fracture of vertebra

+∞

23.0

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

23.0

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

23.0

A07AA09

ATC

vancomycin; oral

5.1

22.6

ZY010

NOMESCO Finland

Hospital outpatient

3.3

22.6

263

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.1

22.4

332

A40.8

ICD-10 Finland

Other streptococcal sepsis

5.4

22.4

SPAT1255

SPAT

Intravenous administration of medicine

2.4

22.2

158

687

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

5.5

22.2

ZYC01

NOMESCO Finland

Remote contact by phone

2.7

22.1

123

475

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

52.7

22.1

D47.1

ICD-10 Finland

Chronic myeloproliferative disease

+∞

21.9

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

21.9

R4190

NOMESCO Finland

Nutritional therapy

4.0

21.9

158

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

222.5

21.6

J01CA04

ATC

amoxicillin; systemic

1.7

21.6

1375

11659

ED1AA

NOMESCO Finland

Mandibular X-ray examination

17.7

21.3

WX402

NOMESCO Finland

General anaesthesia

1.9

21.2

319

1847

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

21.2

306

1748

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.9

21.1

104

377

TPH07

NOMESCO Finland

Cathetrisation of artery

2.1

21.0

223

1143

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.9

20.9

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

21.8

20.8

R4110

NOMESCO Finland

Physiotherapy

1.7

20.7

486

3203

A28

ICPC

Limited function/disability NOS

1.7

20.7

454

2938

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

212.3

20.6

L57.0

ICD-10 Finland

Actinic keratosis

2.1

20.5

198

979

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

42.2

20.5

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.5

20.4

209

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.1

20.3

205

1031

N02BE01

ATC

paracetamol; systemic, rectal

1.9

20.3

1587

14114

L01XX05

ATC

hydroxycarbamide; oral

32.9

20.2

J02AC03

ATC

voriconazole; systemic

48.6

20.2

B99

ICD-10 Finland

Other and unspecified infectious diseases

4.0

20.1

150

N08.4*E85.9

ICD-10 Finland

Glomerular disorders in amyloidosis

58.2

19.9

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

+∞

19.8

WW306

NOMESCO Finland

Transfer of stem cells from foreign registered donator

+∞

19.8

X76

ICPC

Malignant neoplasm breast female

106.2

19.6

B73

ICPC

Leukaemia

202.1

19.6

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.6

19.5

116

463

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.3

19.4

236

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.4

19.4

221

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

19.3

416

2672

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

4.1

19.3

132

D64.8

ICD-10 Finland

Other specified anaemias

3.9

19.3

150

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.9

18.9

273

1555

SPAT1088

SPAT

Blood transfusion

15.0

18.9

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.8

18.8

349

L71

ICPC

Malignant neoplasm musculoskeletal

+∞

18.8

M36.1*C90.0

ICD-10 Finland

Arthropathy in multiple myeloma

+∞

18.8

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

18.8

A04AD12

ATC

aprepitant; systemic

+∞

18.8

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

18.8

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

18.8

9861/3-C42.1

ICD-O-3

Acute myeloid leukemia, NOS, of bone marrow

+∞

18.8

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

4.5

18.7

101

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

101.1

18.6

D47.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified

38.8

18.6

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

191.9

18.6

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

191.9

18.6

B02.9

ICD-10 Finland

Zoster without complication

2.2

18.5

161

763

N02BF02

ATC

pregabalin; oral

2.4

18.5

138

613

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.4

18.4

208

R80

ICD-10 Finland

Isolated proteinuria

5.9

18.4

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.5

18.3

189

TNE20

NOMESCO Finland

Bone marrow aspiration, pelvis

22.0

18.2

A12AA04

ATC

calcium carbonate; oral

4.3

18.1

108

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.6

17.9

103

405

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

7.0

17.8

H02AB07

ATC

prednisone; oral

1.9

17.8

266

1531

M82.0*C90.0

ICD-10 Finland

Osteoporosis in multiple myelomatosis

+∞

17.7

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

17.7

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

17.7

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

17.7

L01BB05

ATC

fludarabine; systemic

+∞

17.7

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

96.0

17.6

H26.3

ICD-10 Finland

Drug-induced cataract

7.8

17.4

J12.8

ICD-10 Finland

Other viral pneumonia

6.1

17.3

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

5.7

17.3

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7.2

17.0

L04AA06

ATC

mycophenolic acid; systemic

4.3

16.9

101

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

6.3

16.8

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

35.4

16.7

YNB00

NOMESCO Finland

Excision of bone marrow for transplantation

171.5

16.5

R06AE07

ATC

cetirizine; oral

1.5

16.4

662

4924

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.4

16.4

173

D45

ICD-10 Finland

Polycythaemia vera

40.5

16.3

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

16.0

303

1870

TQW99

NOMESCO Finland

Other minor procedure on skin

2.7

15.8

329

M49.5

ICD-10 Finland

Collapsed vertebra in diseases classified elsewhere

60.6

15.8

1AA01, ,

NOMESCO Finland

60.6

15.8

UJF32

NOMESCO Finland

Coloscopy

1.6

15.7

466

3225

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

5.9

15.7

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

15.6

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

15.6

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

15.6

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

15.6

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

+∞

15.6

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

+∞

15.6

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

15.6

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

85.8

15.6

N05BA06

ATC

lorazepam; systemic, sublingual

2.4

15.5

113

496

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

15.5

701

5325

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

13.9

15.5

ZX100

NOMESCO Finland

Oral

4.5

15.4

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.9

15.3

244

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.5

15.3

156

D46.9

ICD-10 Finland

Myelodysplastic syndrome, unspecified

17.9

15.2

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

14.1

15.0

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

14.9

160

821

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

14.9

400

2699

XW4XT

NOMESCO Finland

Biopsy of other inner organ with radiological guidance guidance

57.2

14.8

3XA02, ,

NOMESCO Finland

57.2

14.8

XX1AD

NOMESCO Finland

Other CT-examination

57.2

14.8

J01MA02

ATC

ciprofloxacin; systemic

1.5

14.8

695

5311

R11

ICD-10 Finland

Nausea and vomiting

2.0

14.7

157

805

B99

ICPC

Blood/lymph/spleen disease other

21.2

14.7

C91.9

ICD-10 Finland

Lymphoid leukaemia, unspecified

+∞

14.6

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

14.6

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

+∞

14.6

390

Kela drug reimbursment

Ibrutinib

+∞

14.6

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

+∞

14.6

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

14.6

L01XX52

ATC

venetoclax; oral

+∞

14.6

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

14.6

399

Kela drug reimbursment

Venetoclax

+∞

14.6

9835/3-C42.1

ICD-O-3

Precursor cell lymphoblastic leukemia, NOS, of bone marrow

+∞

14.6

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

14.6

E85.3

ICD-10 Finland

Secondary systemic amyloidosis

80.8

14.6

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

14.3

14.5

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.5

14.5

367

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.1

14.4

203

A41.8

ICD-10 Finland

Other specified sepsis

3.3

14.4

172

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

5.6

14.3

C10AA07

ATC

rosuvastatin; oral

0.6

14.3

337

4917

6BA02, ,

NOMESCO Finland

27.4

14.3

D46.7

ICD-10 Finland

Other myelodysplastic syndromes

22.4

14.2

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.2

14.2

174

A02BC01

ATC

omeprazole; systemic

1.5

14.1

497

3565

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

4.0

14.1

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.2

13.9

120

566

3025

Kela drug reimbursment

Calcium carbonate

6.1

13.9

Z2221

NOMESCO Finland

Medical doctor

1.6

13.8

421

2921

TGC00

NOMESCO Finland

Bronchial lavation

3.1

13.7

193

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

10.5

13.7

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.7

13.7

265

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

5.7

13.7

C50

ICD-10 Finland

Malignant neoplasm of breast

75.7

13.6

1512

Kela drug reimbursment

Ibrutinib

+∞

13.6

L01XE27

ATC

[U] ibrutinib

+∞

13.6

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

+∞

13.6

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

13.6

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

13.6

JN4BG

NOMESCO Finland

Body MRI with high intensity magnet

+∞

13.6

L02BG03

ATC

anastrozole; oral

+∞

13.6

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

13.6

L02BX02

ATC

degarelix; parenteral

+∞

13.6

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

13.6

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

13.6

L02BB04

ATC

enzalutamide; oral

+∞

13.6

R79.8

ICD-10 Finland

Other specified abnormal findings of blood chemistry

5.9

13.5

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

13.4

1099

9291

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

21.3

13.3

A03

ICPC

Fever

1.8

13.3

227

1356

ZX114

NOMESCO Finland

Intramuscular

5.2

13.2

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.8

13.1

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.6

13.1

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.0

13.1

137

697

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

4.3

12.9

L01AA02

ATC

chlorambucil; oral

50.4

12.8

B03BA03

ATC

hydroxocobalamin; parenteral

2.1

12.8

132

667

J01DB01

ATC

cefalexin; oral

1.5

12.8

1363

12063

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

14.1

12.8

L04AA01

ATC

[U] ciclosporin

4.2

12.7

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

12.7

415

2918

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

12.7

188

1075

V03AE01

ATC

polystyrene sulfonate; oral

3.9

12.6

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

12.6

723

5692

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

15.5

12.6

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.7

12.6

111

KAC10

NOMESCO Finland

Total nephrectomy with capsule

70.4

12.6

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

70.4

12.6

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

12.5

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

12.5

NB4DA

NOMESCO Finland

Bilateral scapula X-ray examination

+∞

12.5

197

Kela drug reimbursment

Sunitinib

+∞

12.5

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

12.5

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

12.5

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

12.5

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

12.5

C96.9

ICD-10 Finland

Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified

+∞

12.5

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

12.5

L03AA04, ,

ATC

130.9

12.4

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

14.4

12.3

Z2446

NOMESCO Finland

Social worker

2.2

12.2

101

469

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

12.1

357

2453

E83.51

ICD-10 Finland

Hypocalcemia

5.7

12.0

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.0

11.9

124

629

J12.2

ICD-10 Finland

Parainfluenza virus pneumonia

47.0

11.9

N18.0

ICD-10 Finland

End-stage renal disease

4.1

11.9

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.4

11.8

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

11.8

323

2180

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

10.6

11.8

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.5

11.7

293

J01FF01

ATC

clindamycin; systemic

1.5

11.7

441

3193

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.6

11.7

264

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

30.2

11.6

XQ848

NOMESCO Finland

Dermatological photography

2.9

11.6

190

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

65.4

11.6

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

19.1

11.6

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

11.5

335

2290

A10AB05

ATC

insulin aspart; parenteral

1.9

11.5

157

875

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

11.5

WF090

NOMESCO Finland

Profylactic radiotherapy

+∞

11.5

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

11.5

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

11.5

372

Kela drug reimbursment

Idelalisib

+∞

11.5

128

Kela drug reimbursment

Cancers of female genital organs

+∞

11.5

N08.1

ICD-10 Finland

Glomerular disorders in neoplastic diseases

+∞

11.5

1518, ,

Kela drug reimbursment

+∞

11.5

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

11.5

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

11.5

L02AE04

ATC

triptorelin; parenteral

+∞

11.5

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

120.8

11.4

NB3AA

NOMESCO Finland

Clavicle X-ray examination

3.7

11.4

121

Kela drug reimbursment

Severe hypofunction of sexual glands

3.5

11.4

114

B01AB04

ATC

dalteparin; parenteral

2.3

11.3

366

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

11.9

11.3

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

11.3

438

3184

R06.0

ICD-10 Finland

Dyspnoea

1.5

11.3

523

3938

1XC02, ,

NOMESCO Finland

10.6

11.3

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.5

11.1

271

N03AX12

ATC

[U] gabapentin; oral

1.6

11.0

282

1870

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

11.0

201

1222

C10AC01

ATC

colestyramine; oral

2.9

10.9

175

WX892

NOMESCO Finland

Monitored bed care

1.9

10.9

143

787

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.4

10.8

118

H02AB04

ATC

methylprednisolone; systemic

1.6

10.8

250

1616

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.3

10.8

336

WX720

NOMESCO Finland

Own respiration

2.2

10.8

453

A10AC01

ATC

insulin (human); parenteral

1.8

10.8

163

938

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

8.9

10.8

M54.5

ICD-10 Finland

Low back pain

1.4

10.7

572

4417

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

10.6

195

3057

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

10.6

247

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

3.7

10.5

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

10.5

551

4236

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

3.4

10.4

106

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

10.4

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

10.4

L02BA03

ATC

fulvestrant; parenteral

+∞

10.4

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

10.4

192

Kela drug reimbursment

Fulvestrant

+∞

10.4

9731/3-C41.2

ICD-O-3

Plasmacytoma, NOS, of vertebral column

+∞

10.4

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

10.4

9961/3-C42.1

ICD-O-3

Primary myelofibrosis of bone marrow

+∞

10.4

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

10.4

9761/3-C42.0

ICD-O-3

Waldenstrom macroglobulinemia of blood

+∞

10.4

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

10.4

9731/3-C41.3

ICD-O-3

Plasmacytoma, NOS, of rib, sternum, clavicle and associated joints

+∞

10.4

NAR00

NOMESCO Finland

Complete excision of tumour of bone or cartilage of spine, unspecified

+∞

10.4

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

10.4

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

10.4

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

10.3

143

801

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

10.7

10.3

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.1

10.3

435

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

18.9

10.3

WPB10

NOMESCO Finland

Making a convalescent care decision

18.9

10.3

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

23.5

10.2

S77

ICPC

Malignant neoplasm of skin

23.5

10.2

B82

ICPC

Anaemia other/unspecified

2.4

10.2

288

KCD02

NOMESCO Finland

Transurethral resection of bladder

7.5

10.2

ZXC50

NOMESCO Finland

Cryotherapy

2.8

10.2

182

ZXC20

NOMESCO Finland

Use of chemical agents

3.6

10.1

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.3

10.1

340

XX1VW

NOMESCO Finland

Written report from radiologist

5.0

10.0

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

9.9

310

2148

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.2

9.9

382

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.4

9.9

280

M48.5

ICD-10 Finland

Collapsed vertebra, not elsewhere classified

8.2

9.8

K10.20

ICD-10 Finland

Osteomyelitis (neonatal) of jaw (acute)(chronic)(suppurative)

20.1

9.8

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

4.0

9.8

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

3.5

9.8

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

9.7

302

2089

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

9.6

201

1265

ZXC96

NOMESCO Finland

Robot assisted procedure

7.9

9.6

S42.3

ICD-10 Finland

Fracture of shaft of humerus

3.4

9.6

102

J02AC01

ATC

fluconazole; systemic

1.4

9.6

515

3965

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

4.6

9.5

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

9.1

9.5

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

9.5

306

2133

N06DX01

ATC

memantine; oral

0.5

9.5

1424

L02BG06

ATC

exemestane; oral

100.5

9.4

W0X00

NOMESCO Finland

Estimation of continuous need for medical therapy

17.6

9.4

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.3

9.4

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

9.4

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

9.4

159

Kela drug reimbursment

Pazopanib

+∞

9.4

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

9.4

C09.0

ICD-10 Finland

Malignant neoplasm: Tonsillar fossa

+∞

9.4

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

9.4

9950/3-C42.1

ICD-O-3

Polycythemia vera of bone marrow

+∞

9.4

D46.2

ICD-10 Finland

Refractory anaemia with excess of blasts [RAEB]

+∞

9.4

3AA13, ,

NOMESCO Finland

+∞

9.4

C95.9

ICD-10 Finland

Leukaemia, unspecified

+∞

9.4

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

9.4

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

9.4

L03AB04

ATC

interferon alfa-2a; parenteral

+∞

9.4

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

9.4

L01XX47

ATC

[U] idelalisib

+∞

9.4

C95.0

ICD-10 Finland

Acute leukaemia of unspecified cell type

+∞

9.4

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

9.4

D69.5

ICD-10 Finland

Secondary thrombocytopenia

21.8

9.3

WPA13

NOMESCO Finland

Palliative consultation

9.6

9.3

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.3

9.2

289

M54.6

ICD-10 Finland

Pain in thoracic spine

1.9

9.2

113

609

R93.7

ICD-10 Finland

Abnormal findings on diagnostic imaging of other parts of musculoskeletal system

13.7

9.2

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

13.7

9.2

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.4

9.1

247

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.8

9.1

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

4.8

9.1

B00.2

ICD-10 Finland

Herpesviral gingivostomatitis and pharyngotonsillitis

11.5

9.1

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

9.0

204

1310

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

18.7

8.9

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.5

8.9

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

24.1

8.9

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

24.1

8.9

K10.25

ICD-10 Finland

Sequences of jawbones

8.0

8.8

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

6.8

8.8

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

3.1

8.8

113

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

4.0

8.8

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

10.7

8.8

NFR20

NOMESCO Finland

Incomplete excision of soft tissue tumour of hip or thigh

14.1

8.7

NK6AT

NOMESCO Finland

Bone biopsy with ultrasound guidance

50.2

8.7

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.6

8.6

193

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

4.6

8.6

L04AD02

ATC

tacrolimus; systemic

4.8

8.6

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

8.6

242

1637

Z3226

NOMESCO Finland

Physiotherapist

1.5

8.6

279

1948

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

16.4

8.6

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.5

8.5

218

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.1

8.5

399

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.9

8.4

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

90.5

8.4

N08.2*D89.82

ICD-10 Finland

Nepropathy caused by deposition of the light chain of the immunoglobulins

90.5

8.4

N06DA02

ATC

donepezil; oral

0.4

8.4

1083

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.2

8.4

295

I50.9

ICD-10 Finland

Heart failure, unspecified

1.4

8.4

355

2610

9989/3-C42.1

ICD-O-3

Myelodysplastic syndrome, NOS, of bone marrow

+∞

8.3

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

8.3

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

8.3

JN4DG

NOMESCO Finland

Body very extensive MRI with high intensity magnet

+∞

8.3

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

+∞

8.3

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

8.3

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

8.3

3054, ,

Kela drug reimbursment

+∞

8.3

GA5DA

NOMESCO Finland

Bilateral rib X-ray exmaination

+∞

8.3

198

Kela drug reimbursment

Sorafenib

+∞

8.3

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

8.3

1523, ,

Kela drug reimbursment

+∞

8.3

1XX45, ,

NOMESCO Finland

+∞

8.3

9731/3-C41.4

ICD-O-3

Plasmacytoma, NOS, of pelvic bones, sacrum, coccyx and associated joints

+∞

8.3

C91.7

ICD-10 Finland

Other lymphoid leukaemia

+∞

8.3

L01CA04

ATC

vinorelbine; systemic

+∞

8.3

J21.0

ICD-10 Finland

Acute bronchiolitis due to respiratory syncytial virus

10.8

8.3

WX882

NOMESCO Finland

High dependency care

2.5

8.2

204

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.0

8.2

113

C10AX09

ATC

ezetimibe; oral

0.6

8.1

160

2478

B59

ICD-10 Finland

Pneumocystosis

33.5

8.1

D03.5

ICD-10 Finland

Melanoma in situ of trunk

17.2

8.1

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

10.1

8.0

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

22.1

8.0

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

8.0

261

1823

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

8.0

430

TPH04, ,

SPAT

3.5

8.0

OAB42, ,

SPAT

0.5

7.9

1518

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

7.9

201

1327

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

4.0

7.9

ZXA05

NOMESCO Finland

Left side

1.4

7.9

401

3044

N02AA01

ATC

morphine; systemic, rectal

3.1

7.9

105

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

3.1

7.9

105

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

8.5

7.8

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

7.8

143

870

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.6

7.7

162

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

45.2

7.7

TPX15

NOMESCO Finland

Removal of vascular injection port

15.1

7.7

DMW00

NOMESCO Finland

Intubation of maxillary antrum

15.1

7.7

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

7.7

387

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

7.7

398

3029

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

4.4

7.7

C08CA01

ATC

amlodipine; oral

1.3

7.7

772

6506

TK810

NOMESCO Finland

Hemofiltration

4.5

7.7

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.6

7.6

K10.21

ICD-10 Finland

Osteoradionecrosis of jaw (acute)(chronic)(suppurative)

11.9

7.6

B01.9

ICD-10 Finland

Varicella without complication

11.9

7.6

J20.4

ICD-10 Finland

Acute bronchitis due to parainfluenza virus

25.1

7.6

WX704

NOMESCO Finland

Intubation

1.8

7.6

114

656

PJA10

NOMESCO Finland

Exploration of lymph nodes

7.1

7.5

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.1

7.5

330

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

7.4

399

NA7CM

NOMESCO Finland

Spine and spinal cord extensive MRI examination with 3 Tesla magnet

80.4

7.4

DAB10

NOMESCO Finland

Partial excision of auricle

80.4

7.4

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.4

7.4

214

R04.0

ICD-10 Finland

Epistaxis

1.7

7.4

147

914

RD210, ,

NOMESCO Finland

3.3

7.4

SPAT1254

SPAT

Administration of medicine

1.5

7.4

258

1826

B02AA02

ATC

tranexamic acid; systemic

1.6

7.3

161

1027

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

7.3

WB323

NOMESCO Finland

Demanding adjuvant therapy of malignancy with biomodifiers

+∞

7.3

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

7.3

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

7.3

L01XE04

ATC

[U] sunitinib

+∞

7.3

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

7.3

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

7.3

L01XE11

ATC

[U] pazopanib

+∞

7.3

9962/3-C42.1

ICD-O-3

Essential thrombocythemia of bone marrow

+∞

7.3

NA049

NOMESCO Finland

Radiotherapy of methastasis in spine

+∞

7.3

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

7.3

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

7.3

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

7.3

L02BX03

ATC

abiraterone; oral

+∞

7.3

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

7.3

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

7.3

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

7.3

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

7.3

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

7.3

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

+∞

7.3

L01XE18

ATC

[U] ruxolitinib

+∞

7.3

1AA09, ,

NOMESCO Finland

+∞

7.3

174

Kela drug reimbursment

Ruxolitinib

+∞

7.3

AA1AD

NOMESCO Finland

CT of head and brain

1.3

7.3

563

4562

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

7.2

148

927

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

7.2

517

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.7

7.2

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

7.2

690

5764

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

20.1

7.1

R93.5

ICD-10 Finland

Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum

3.5

7.1

L02AE03

ATC

goserelin; implant

12.1

7.1

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

6.0

7.1

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

7.0

216

1487

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.5

7.0

182

DHB00

NOMESCO Finland

Excision of lesion of external nose

10.1

7.0

E85.4

ICD-10 Finland

Organ-limited amyloidosis

10.1

7.0

XKD00

NOMESCO Finland

Uroflowmetry

1.5

7.0

263

1885

B34.9

ICD-10 Finland

Viral infection, unspecified

2.5

7.0

170

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

7.0

296

2171

J94.8

ICD-10 Finland

Other specified pleural conditions

2.9

7.0

113

NB6AD

NOMESCO Finland

Upper arm CT

13.8

6.9

Z31.5

ICD-10 Finland

Genetic counselling

2.5

6.9

160

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

6.8

566

4622

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

6.8

237

1675

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

11.0

6.8

D75.2

ICD-10 Finland

Essential thrombocytosis

9.3

6.8

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

6.8

434

J20.6

ICD-10 Finland

Acute bronchitis due to rhinovirus

16.8

6.7

L28

ICPC

Limited function/disability (L)

1.4

6.7

384

2963

UKC02

NOMESCO Finland

Cystoscopy

1.4

6.7

272

1978

WW400

NOMESCO Finland

Plasmaferesis

22.6

6.7

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.1

6.7

297

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.9

6.6

105

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

2.9

6.6

105

HAB99

NOMESCO Finland

Other partial excision of mammary gland

5.9

6.6

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

5.5

6.6

RS221, ,

NOMESCO Finland

3.4

6.6

S42.0

ICD-10 Finland

Fracture of clavicle

2.3

6.5

221

N39.1

ICD-10 Finland

Persistent proteinuria, unspecified

5.3

6.5

P01AB01

ATC

metronidazole; oral, rectal

1.3

6.5

571

4700

B01AF02

ATC

apixaban; oral

1.4

6.4

292

2167

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

70.1

6.4

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

70.1

6.4

ZXY12

NOMESCO Finland

Trainee nurse, supervised

70.1

6.4

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

70.1

6.4

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

70.1

6.4

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

14.4

6.4

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.4

6.3

185

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.2

6.3

230

J04BA02

ATC

dapsone; oral

5.5

6.3

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

9.3

6.3

5AB14, ,

NOMESCO Finland

18.1

6.3

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

6.3

9863/3-C42.1

ICD-O-3

Chronic myeloid leukemia, NOS, of bone marrow

+∞

6.3

1501

Kela drug reimbursment

Palbociclib

+∞

6.3

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

+∞

6.3

NK6BT

NOMESCO Finland

Bone biopsy with X-ray guidance

+∞

6.3

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

+∞

6.3

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

+∞

6.3

20399

ICD-8 Finland

Multiple myeloma

+∞

6.3

E85

ICD-10 Finland

Amyloidosis

+∞

6.3

L01EJ01

ATC

ruxolitinib; oral

+∞

6.3

M907, C6488,

ICD-10 Finland

+∞

6.3

394

Kela drug reimbursment

Palbociclib

+∞

6.3

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

+∞

6.3

189

Kela drug reimbursment

Imatinib

+∞

6.3

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

6.3

1502

Kela drug reimbursment

Cabozantinib

+∞

6.3

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

6.3

8090/3-C44.0

ICD-O-3

Basal cell carcinoma, NOS, of skin of lip, NOS

+∞

6.3

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

6.3

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

6.3

374

Kela drug reimbursment

Ruxolitinib

+∞

6.3

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

6.3

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

6.3

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

6.3

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

6.3

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

6.3

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

6.3

343

Kela drug reimbursment

Pazopanib

+∞

6.3

3012

Kela drug reimbursment

Cabozantinib

+∞

6.3

WE100

NOMESCO Finland

Profylactic cytostatic therapy

+∞

6.3

L01EF01

ATC

palbociclib; oral

+∞

6.3

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

6.3

L01XE05

ATC

[U] sorafenib

+∞

6.3

9731/3-C41.9

ICD-O-3

Plasmacytoma, NOS, of bone, NOS

+∞

6.3

B01.8

ICD-10 Finland

Varicella with other complications

+∞

6.3

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

+∞

6.3

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

26.8

6.2

WX002

NOMESCO Finland

Sedation and analgesia

1.4

6.2

309

2329

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

7.0

6.2

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.5

6.2

144

WVA20, ,

SPAT

2.0

6.1

314

WNF00

NOMESCO Finland

Infection source and contact determination

7.7

6.1

TJF80

NOMESCO Finland

Ostomy education

7.7

6.1

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

6.1

413

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.7

6.1

116

N05AX08

ATC

risperidone; systemic

0.5

6.1

1189

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.6

6.0

134

137

Kela drug reimbursment

Uraemia requiring dialysis

3.6

6.0

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.6

6.0

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

6.0

281

2094

A40.9

ICD-10 Finland

Streptococcal sepsis, unspecified

6.7

6.0

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

10.1

6.0

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.5

6.0

1122

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3026493) Urate [Moles/volume] in Serum or Plasma

1191

4242

6.17

323.01

9.7

2.6

330.83

360.67

umol/l

16.10

1157

3600

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

344

352

11.80

308.73

2.6

1.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

947

2166

7.98

307.65

11.3

5.3

1.08

1.03

mmol/l

4.69

922

1986

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1205

596

57.21

307.65

21.8

1.5

113.11

34.62

mg/l

6.17

1132

501

(3017143) Hepatitis C virus Ab [Presence] in Serum

672

1097

9.10

307.65

1.8

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

720

1411

7.76

307.65

1.8

1.6

—

(21494434) Karyotype in Bone marrow

380

58.94

307.65

1.2

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

734

164

74.03

307.65

1.8

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

610

660

13.36

307.65

1.7

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

270

154

20.39

307.65

2.4

2.5

183.21

342.59

u/ml

0.59

(3017704) Immunofixation for Urine

329

101

39.49

307.65

4.2

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

921

744

23.90

307.65

16.4

1.4

3.75

3.74

g/l

0.02

907

658

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

733

1187

9.63

307.65

2.0

1.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1089

967

26.32

307.65

11.4

2.2

12.65

11.04

g/l

4.13

1048

889

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

854

697

22.09

307.65

17.1

1.4

2.55

2.97

g/l

19.03

840

611

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

853

644

23.93

307.65

16.7

1.5

6.96

0.43

g/l

50.19

709

548

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

922

746

23.88

307.65

16.5

1.4

6.98

7.50

g/l

11.32

908

659

(3045142) Bone marrow Pathology biopsy report

372

65.50

307.65

1.3

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1215

1669

19.67

307.65

12.8

2.0

227.13

233.74

u/l

1.05

1195

1547

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

456

497

11.89

307.65

21.7

1.5

0.00

g/l

-0.00

446

465

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

684

666

15.80

307.65

18.5

1.4

11.01

10.40

g/l

0.85

650

574

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

603

546

15.98

307.65

17.6

1.5

0.20

0.00

g/l

4.23

498

493

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

573

527

15.37

307.65

18.1

1.4

0.00

g/l

0.93

446

466

(3023520) Reticulocytes [#/volume] in Blood

926

1627

10.49

307.65

4.4

2.0

60.95

67.59

e9/l

6.05

728

1203

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

921

745

23.86

307.65

16.5

1.4

4.24

4.20

g/l

0.24

906

659

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

401

209

24.29

307.65

6.4

5.6

286.70

574.13

iu/ml

0.70

(3027945) Reticulocytes/Erythrocytes in Blood

1048

2090

10.39

307.65

4.8

2.0

1.67

1.78

3.04

1011

1831

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

248

238.89

307.65

1.2

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1205

599

56.92

307.65

21.8

1.5

247.62

46.41

mg/l

2.58

1133

506

(3020630) Protein [Mass/volume] in Serum or Plasma

1262

1478

25.26

307.65

22.4

1.6

67.16

66.47

g/l

1.40

1239

1332

(3036603) Volume of Urine

269

33.73

307.65

3.3

1.5

1874.35

1887.70

0.05

269

(3007164) IgA [Mass/volume] in Serum or Plasma

1021

2572

7.71

307.65

8.0

1.3

3.31

2.75

g/l

1.71

903

1436

(3037756) Immunofixation for Serum or Plasma

1044

331

72.05

307.65

4.9

1.2

—

(3047189) Immunofixation for 24 hour Urine

641

151.20

307.65

3.0

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1138

536

54.45

307.65

19.8

1.5

29.41

1.62

ratio

2.88

849

317

(3028026) IgM [Mass/volume] in Serum or Plasma

937

766

24.01

307.65

6.4

1.4

0.76

1.15

g/l

3.08

798

702

(3020876) Protein [Mass/time] in 24 hour Urine

733

185

65.40

307.65

4.5

1.8

0.84

1.52

g/24h

1.17

535

100

(4035726) Immunohistochemistry procedure

392

367

13.32

307.65

1.5

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

894

155

111.75

307.65

4.9

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

362

360

12.29

307.65

2.7

1.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

863

2497

5.65

292.90

6.3

2.5

0.80

0.82

mmol/l

7.17

838

2299

(3004809) Band form neutrophils/Leukocytes in Blood

254

176

16.60

288.69

5.0

2.6

1.79

1.50

0.31

236

143

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

294

273

12.64

280.80

1.4

1.1

84.29

20.70

u/l

8.30

281

235

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

333

374

10.66

278.76

1.9

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

274

359.89

277.75

1.4

1.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

182

31.97

276.90

8.0

1.2

40.74

38.61

g/l

1.74

182

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

265

216

14.18

274.41

1.6

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

258

244

12.14

242.56

2.8

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

521

1133

6.03

238.72

2.4

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

121

107.90

235.33

1.2

1.1

—

(3017181) Myelocytes/Leukocytes in Blood

549

1279

5.70

232.68

9.4

3.9

1.04

0.74

2.38

409

269

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

434

843

6.44

222.93

2.3

1.6

1.38

1.53

g/l

2.56

396

732

(42870588) Differential panel, method unspecified - Blood

1159

5002

4.59

221.62

15.9

5.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

847

3010

4.38

208.76

3.6

1.9

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

137

31.43

208.33

2.0

2.2

33.00

47.65

4.91

(3023368) Bacteria identified in Blood by Culture

1089

4640

4.32

208.14

8.5

4.1

—

(3006504) Eosinophils/Leukocytes in Blood

1367

6882

4.89

206.68

18.9

5.7

2.68

2.98

4.74

1344

6360

(3019069) Monocytes/Leukocytes in Blood

1368

6893

4.89

206.53

19.2

5.8

9.99

9.15

16.08

1346

6363

(3024561) Albumin [Mass/volume] in Serum or Plasma

1375

7014

4.86

202.54

22.8

4.0

34.23

35.24

g/l

8.44

1342

6492

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

180

126

15.73

202.18

3.1

1.3

—

(3002179) Metamyelocytes/Leukocytes in Blood

505

1225

5.31

201.90

10.0

3.7

0.74

0.64

0.37

381

264

(3002030) Lymphocytes/Leukocytes in Blood

1366

6993

4.75

198.64

19.2

5.7

28.46

26.37

7.85

1352

6544

(3018010) Neutrophils/Leukocytes in Blood

1353

6902

4.68

197.07

18.0

5.7

54.86

58.39

19.81

1335

6513

(3022096) Basophils/Leukocytes in Blood

1350

6894

4.65

195.85

19.2

5.8

0.63

0.67

1.34

1327

6361

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

182

138

14.53

195.38

3.1

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

315

503

7.36

194.64

1.5

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

750

2571

4.25

191.37

3.2

1.9

28.59

29.73

5.66

728

2496

(3001604) Monocytes [#/volume] in Blood

1412

7527

4.83

191.11

19.7

5.5

0.55

0.62

e9/l

21.89

1299

6333

(3017354) Segmented neutrophils/Leukocytes in Blood

176

131

14.76

190.89

5.3

2.4

56.08

59.53

0.90

158

104

(3006315) Basophils [#/volume] in Blood

1413

7560

4.81

189.64

19.6

5.5

0.03

0.04

e9/l

45.83

1298

6365

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

197

185

11.81

185.05

1.4

142.09

155.03

au/ml

0.55

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1413

7645

4.72

184.47

20.8

3.9

10.31

12.38

umol/l

15.31

1398

7168

(3019198) Lymphocytes [#/volume] in Blood

1415

7679

4.71

183.55

19.8

5.6

1.65

1.81

e9/l

2.05

1318

6628

(3013115) Eosinophils [#/volume] in Blood

1424

7782

4.73

182.44

20.6

5.6

0.15

0.21

e9/l

19.61

1317

6666

(3013650) Neutrophils [#/volume] in Blood by Automated count

1450

8031

4.87

182.34

45.1

6.3

3.14

4.39

e9/l

104.55

1346

6805

(3004789) Transferrin [Mass/volume] in Serum or Plasma

740

2629

4.05

177.33

3.5

2.7

2.10

2.26

g/l

12.53

713

2396

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

701

2420

4.07

174.60

3.6

2.7

24.31

22.14

4.06

681

2222

(3021440) Promyelocytes/Leukocytes in Blood

478

1245

4.84

173.23

10.0

3.9

0.13

0.07

1.45

347

236

(3020779) Urea [Moles/volume] in Serum or Plasma

542

1561

4.51

172.75

10.1

6.5

12.59

11.28

mmol/l

2.75

523

1474

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

141

17.89

170.73

3.5

2.2

11.03

50.62

iu/ml

1.29

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

111

31.87

169.98

3.7

1.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

674

2303

4.05

169.63

2.8

1.8

—

(3018418) pH of Serum or Plasma

1052

4844

3.75

168.98

27.1

3.5

7.39

7.40

1.10

881

3517

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

121

24.37

168.46

3.5

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

121

24.37

168.46

3.5

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

121

24.37

168.46

3.5

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

121

24.37

168.46

3.5

1.1

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1451

8292

4.61

168.16

39.8

6.2

1.21

mmol/l

0.15

1363

7120

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

110

31.57

167.95

3.6

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

110

31.57

167.95

3.6

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

152

111

14.84

166.33

3.2

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

152

111

14.84

166.33

3.2

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

152

111

14.84

166.33

3.2

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1352

7405

4.16

165.29

31.3

5.9

1.21

mmol/l

2.28

1327

6701

(3022948) Iron [Moles/volume] in Serum or Plasma

755

2839

3.82

164.37

3.6

2.7

12.91

12.45

umol/l

1.05

729

2606

(3012565) Volume of 24 hour Urine

125

20.25

160.94

6.4

2.2

2074.06

1829.75

1.03

125

(3025159) Blasts/Leukocytes in Blood

466

1265

4.60

159.20

11.0

4.1

0.27

0.01

1.76

335

217

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

134

17.13

159.00

1.7

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

152

120

13.72

158.90

5.0

3.0

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

296

551

6.22

156.13

1.7

1.2

—

(40758292) HTLV I+II Ab panel - Serum

158

191.95

153.29

1.7

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

227

326

7.81

153.24

1.3

—

(3011412) CD3 cells [#/volume] in Blood

118

19.95

151.08

2.9

1.7

1046.25

1172.05

e6/l

0.50

106

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

193

234

9.10

149.99

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

159

148

11.67

149.73

4.3

2.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

219

313

7.81

148.35

1.8

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

33.73

145.11

2.1

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

177

201

9.64

144.62

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

138

109

13.61

144.05

1.1

1.0

—

(3000012) Reticulocyte production index

192

246

8.60

142.59

3.4

1.7

0.80

0.88

1.17

167

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

145

224.75

142.08

3.9

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

199

268

8.21

141.76

1.6

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

599

2137

3.68

137.45

2.9

1.8

—

(44790048) Parainfluenza type 2 nucleic acid detection

162

176

10.00

136.71

2.0

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

162

176

10.00

136.71

2.0

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

162

176

10.00

136.71

2.0

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

162

176

10.00

136.71

2.0

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

195

273

7.88

134.21

1.6

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

938

4485

3.24

132.49

7.6

2.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

133

179.11

128.26

9.8

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

205

329

6.89

124.41

3.4

2.2

3.70

3.54

g/l

0.69

200

311

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

106

16.01

122.11

1.5

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

106

16.01

122.11

1.5

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1010

5258

3.05

119.12

9.3

2.1

2.32

2.35

mmol/l

6.52

964

4589

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

24.79

116.84

3.7

2.9

1.30

0.90

1.00

(1175426) CD3 cells/Lymphocytes in Blood

20.09

116.08

2.4

2.0

70.23

72.83

0.42

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

100

15.97

115.17

3.0

1.7

—

(3035933) Granulocytes/Leukocytes in Blood

172

255

7.34

112.13

5.6

3.2

50.01

58.57

8.65

172

255

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

145

179

8.71

110.54

1.7

1.4

—

(3044927) Protein electrophoresis panel - Urine

161

227

7.68

109.73

1.7

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

21.16

109.61

2.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

176

276

6.95

108.87

1.9

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

144

190

8.14

103.83

1.8

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

114

111

10.89

103.68

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1119

6512

2.85

101.45

7.3

2.5

—

estimate

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

446

1573

3.43

100.68

6.8

2.2

6.00

7.83

umol/l

2.09

403

1381

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

405

1356

3.55

99.09

4.4

3.8

91.12

95.75

ng/l

0.40

357

1138

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

279

719

4.40

99.09

2.5

1.7

2.05

1.85

ug/l

0.12

254

623

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

723

3422

2.84

96.80

7.0

2.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

13.40

96.17

2.2

6.2

—

70.39

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

138

192

7.69

94.96

1.5

1.2

207.12

267.52

u/ml

1.00

108

(3037121) Protein [Mass/volume] in Urine

231

530

4.84

94.79

2.5

2.7

700.47

310.35

mg/l

3.45

156

188

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

149

227

7.06

94.48

1.8

1.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

851

4439

2.71

93.43

2.5

2.4

2.76

2.81

mg/l

0.25

749

3783

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

304

873

3.98

92.96

2.8

1.4

5.33

2.74

ug/l

2.06

239

663

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

17.58

92.29

3.8

1.4

225.25

206.78

e6/l

0.19

(21494814) CD8 cells/Lymphocytes in Specimen

26.94

87.20

2.3

2.4

38.50

24.04

5.03

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

221

523

4.67

87.09

3.2

3.0

0.32

0.35

iu/ml

0.64

122

311

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

16.02

85.79

3.3

1.3

619.70

412.79

e6/l

1.46

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

12.66

80.01

2.3

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

12.66

80.01

2.3

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1075

6607

2.52

79.60

4.4

3.0

300.31

137.50

ug/l

15.62

1032

6059

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

105

132

8.38

78.57

1.2

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

104

132

8.29

77.20

1.9

1.6

—

1853.33

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

332

1147

3.31

75.81

2.5

1.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1364

9502

2.71

75.48

16.4

4.8

6.64

6.87

mmol/l

4.49

1340

9038

(3027035) Albumin [Mass/time] in 24 hour Urine

37.08

75.36

1.9

1.2

—

330.12

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

9.61

75.33

2.1

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

9.69

75.02

2.1

1.2

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

106

9.09

73.76

1.4

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

700

3631

2.50

73.62

7.7

3.8

86.97

84.08

2.32

687

3547

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

183

426

4.66

73.27

2.0

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

891

5269

2.35

68.46

4.7

3.4

33.66

77.46

e6/l

1.61

749

4045

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

122

224

5.76

63.98

6.0

6.2

11.01

12.82

mg/l

3.65

112

210

(3032080) INR in Blood by Coagulation assay

1176

7984

2.32

63.14

17.5

19.7

1.29

1.37

inr

2.36

1013

6711

(3021447) Carbon dioxide [Partial pressure] in Venous blood

432

1895

2.67

63.09

6.7

3.4

5.66

5.83

kpa

2.85

426

1840

(3012544) pH of Venous blood

435

1919

2.66

62.78

6.7

3.4

7.38

0.65

285

1116

(3002032) Base excess in Venous blood by calculation

423

1847

2.68

62.26

6.7

3.4

1.25

1.89

mmol/l

2.63

368

1609

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

966

6087

2.24

61.62

5.1

3.3

2007.94

1630.84

ng/l

1.43

899

5310

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

143

314

4.86

61.28

4.0

2.0

223.89

196.58

2.33

138

294

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

162

395

4.40

60.95

4.1

2.9

1.87

1.75

mg/l

0.77

151

344

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

619

3254

2.36

60.93

2.4

1.6

1.58

1.37

mg/l

0.68

529

2573

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

107

183

6.15

60.35

2.4

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

106

180

6.19

60.22

2.5

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

103

171

6.32

59.84

2.5

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

103

171

6.32

59.84

2.5

1.2

—

(40765096) Chromosome analysis panel by Banding

22.52

59.79

1.2

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

106

182

6.12

59.54

2.5

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

110

196

5.91

59.49

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

103

173

6.25

59.15

2.5

1.2

—

(3018095) Leukocytes [#/volume] in Urine

934

5871

2.21

59.12

5.7

3.9

60.74

119.72

e6/l

3.55

759

4182

(3030467) Casts [#/volume] in Urine by Automated count

770

4513

2.22

57.70

4.7

3.3

0.46

0.48

e6/l

0.13

630

3342

(3000991) Gas panel - Venous blood

351

1471

2.71

55.48

10.4

8.0

—

(3017732) Neutrophils [#/volume] in Blood

405

1835

2.55

54.54

7.9

2.8

3.28

4.64

e9/l

11.66

366

1522

(36304419) Bacteria [Presence] in Urine

729

4254

2.19

54.47

4.6

3.2

0.00

400.20

estimate

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

278

1041

2.97

54.23

7.1

3.5

23.59

24.19

mmol/l

2.14

278

1026

(3036489) Thrombin time

171

474

3.88

53.95

3.5

1.7

21.98

20.80

2.21

163

421

(3000850) Epithelial cells [#/volume] in Urine

660

3715

2.21

53.87

3.4

2.6

5.35

5.08

e6/l

0.20

626

3368

(3036481) Cortisol [Moles/volume] in Serum or Plasma

329

1359

2.73

53.35

2.4

1.8

389.09

372.58

nmol/l

0.70

318

1227

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

206

652

3.43

53.29

4.6

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

249

901

3.04

51.50

1.7

1.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

301

1209

2.78

51.40

5.7

3.6

4.79

5.20

kpa

13.15

285

1149

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1478

11528

2.46

50.95

33.8

5.8

79.60

78.17

u/l

0.52

1464

10708

(3009343) pH of Capillary blood

294

1172

2.80

50.90

5.6

3.6

7.43

7.41

3.60

258

970

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

268

1025

2.89

50.10

5.5

3.4

0.99

2.08

mmol/l

4.40

194

728

(40768795) Lymph node Pathology biopsy report

17.45

49.80

1.3

1.0

—

(3021589) Normoblasts [#/volume] in Blood

974

6496

2.07

49.74

34.2

10.7

0.01

0.00

e9/l

1.11

828

5268

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

16.75

48.81

1.3

1.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

846

5396

2.06

48.43

2.2

1.7

18.53

20.20

nmol/l

2.88

800

4457

(3026008) Bacteria identified in Urine by Culture

817

5200

2.03

46.49

3.9

3.5

—

(3035715) Granulocytes [#/volume] in Blood

101

212

4.98

45.51

6.9

3.4

2.81

4.25

e9/l

10.40

101

212

(3026782) Osmolality of Urine

560

3135

2.13

44.79

3.8

2.9

523.07

527.21

mosm/kgh2o

0.20

523

2726

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

12.12

44.66

1.8

2.6

3999.67

4752.86

u/ml

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

110

6.67

44.03

1.3

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

123

6.32

44.03

1.8

1.4

—

(3003694) ABO and Rh group [Type] in Blood

616

3600

2.07

43.75

1.6

1.3

—

(40758558) Short blood count panel - Blood

701

4312

2.01

43.05

24.2

4.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

126

340

3.91

41.13

2.3

1.9

496.29

27.29

u/ml

0.70

102

271

(3042936) Bacteria identified in Isolate by Culture

426

2212

2.21

40.75

2.1

2.0

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

570

3308

2.05

40.73

6.2

2.3

2.49

2.45

mmol/l

6.96

530

2923

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

472

2553

2.14

40.70

4.4

3.1

2.17

2.38

e6/l

0.23

257

1260

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

506

2820

2.10

40.27

4.2

3.0

1.11

1.31

e6/l

0.53

294

1539

(4062490) Immunoglobulin typing, IgG

124

6.00

40.24

1.3

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

10.98

40.07

1.8

1.5

1280.00

4906.67

titre

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

289

1278

2.50

40.01

22.1

3.3

1.22

1.23

mmol/l

1.89

282

1082

(40768804) Tissue Pathology biopsy report

704

4440

1.95

39.39

2.5

1.7

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

127

5.86

39.26

1.4

10.03

7.24

g/l

1.19

(3024139) IgG subclass 3 [Mass/volume] in Serum

127

5.86

39.26

1.4

0.32

0.39

g/l

0.28

(3028192) IgG subclass 2 [Mass/volume] in Serum

127

5.86

39.26

1.4

1.75

2.97

g/l

2.94

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

175

612

3.06

38.04

6.0

3.8

24.13

24.79

mmol/l

2.25

162

553

(3031040) Bacteria [#/volume] in Urine by Automated count

1306

10169

1.99

37.83

6.6

5.0

1393.25

2714.15

e6/l

0.48

162

(3002256) Pathology report gross observation

255

1103

2.52

36.84

1.4

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

571

3415

1.98

36.81

1.9

1.8

1123.02

1150.21

nmol/l

0.27

466

2575

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

173

613

3.01

36.72

3.1

1.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

745

4914

1.87

35.37

3.0

2.4

58.92

61.68

u/l

0.34

712

4502

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

7.36

34.85

1.2

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

151

5.06

34.42

1.2

1.1

—

(3022313) Gas panel - Capillary blood

202

810

2.68

33.97

5.7

3.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

210

4.35

33.85

1.5

1.8

0.36

1.00

g/l

5.51

171

(3007853) Bacteria identified in Skin by Aerobe culture

354

1829

2.16

33.64

1.8

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

130

417

3.28

32.60

1.7

0.24

0.23

g/l

0.23

121

396

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

132

428

3.25

32.53

1.7

1.14

1.17

g/l

0.50

126

403

(3019977) pH of Arterial blood

380

2055

2.07

31.87

8.0

7.1

7.43

7.42

1.06

201

1180

(3014111) Lactate [Moles/volume] in Serum or Plasma

308

1552

2.18

30.99

8.1

6.9

1.26

1.44

mmol/l

3.21

303

1523

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

979

7208

1.77

30.83

3.7

2.4

—

(3016502) Oxygen saturation in Arterial blood

349

1853

2.09

30.64

7.9

7.2

95.24

95.02

0.24

334

1788

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

377

2062

2.04

30.53

8.1

7.1

4.90

5.07

kpa

2.07

359

1980

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

6.02

30.50

1.6

1.3

—

(3003396) Base excess in Arterial blood by calculation

375

2049

2.04

30.44

7.8

7.0

0.69

1.14

mmol/l

1.08

300

1679

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

692

4621

1.80

30.37

6.1

2.7

35.24

36.17

u/l

0.12

670

4317

(3027801) Oxygen [Partial pressure] in Arterial blood

376

2062

2.04

30.19

8.1

7.1

11.78

11.36

kpa

0.95

358

1981

(3024471) HLA-A [Type]

11.66

30.08

1.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

313

1615

2.13

29.54

5.4

2.8

4.66

4.47

kpa

0.74

308

1563

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

112

351

3.33

29.14

1.6

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

112

351

3.33

29.14

1.6

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

151

569

2.80

28.52

2.6

3.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

198

4.12

28.49

1.2

208.02

218.21

miu/ml

0.07

(40768446) Kidney Pathology biopsy report

8.06

28.18

1.2

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

6.21

28.06

1.7

1.4

—

(3024932) HLA-DR beta [Type]

11.32

27.60

1.5

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

5.97

27.51

1.7

1.3

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1372

11354

1.83

26.96

9.2

4.6

33.72

13.05

mm/h

94.66

1330

10545

(1616796) Gas panel - Central venous blood

113

375

3.15

26.75

4.9

4.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

316

1696

2.04

26.64

9.0

7.6

107.94

121.63

g/l

26.22

307

1662

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

916

6794

1.70

26.56

6.0

4.3

46.47

79.86

ng/l

1.57

811

5277

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

152

598

2.68

26.39

1.3

1.9

34.76

38.72

u/l

1.34

138

508

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

23.57

26.14

1.3

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

7.09

25.91

1.1

1.2

—

(3019225) pH of Specimen

300

1603

2.04

25.53

23.9

3.8

7.38

7.36

1.81

279

1041

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

36.15

25.24

1.4

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

36.15

25.24

1.4

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

36.15

25.24

1.4

1.0

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

6.85

25.10

2.0

2.1

1248.62

1002.97

u/ml

0.28

(4212803) Bone marrow aspirate examination

39.41

24.91

1.1

1.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1036

8023

1.67

24.80

2.8

2.3

89.25

94.65

pmol/l

3.63

732

4159

(3001964) Herpes simplex virus Ag [Presence] in Specimen

10.14

24.75

1.1

1.4

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

8.74

24.56

1.5

1.2

—

(3025941) Bacteria identified in Stool by Culture

161

678

2.51

24.30

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

106

360

3.06

24.12

1.3

2.0

15.34

12.50

mg/l

1.68

330

(40763480) Human metapneumovirus Ag [Presence] in Specimen

+∞

24.01

1.5

0.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

247

1263

2.10

23.55

2.4

2.0

0.19

g/l

0.09

230

1147

(3037692) Legionella sp identified in Specimen by Organism specific culture

8.28

23.54

1.1

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

20.35

23.03

2.8

1.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

149

627

2.50

22.50

1.1

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

531

3536

1.71

22.02

6.3

4.3

111.61

400.00

ng/l

6.81

472

3040

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

+∞

21.91

1.6

0.0

—

(3015736) pH of Urine

865

6577

1.60

20.86

4.1

3.6

6.31

6.29

0.14

446

3555

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

924

7145

1.59

20.68

3.1

2.4

82.07

79.41

nmol/l

1.98

870

6252

(3021601) Nitrite [Presence] in Urine by Test strip

1037

8249

1.59

20.50

4.8

4.1

0.00

estimate

0.50

238

1680

(40768800) Prostate Pathology biopsy report

5.10

20.49

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

135

4.17

20.43

1.3

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

307

3.03

20.34

1.3

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

136

4.14

20.23

1.3

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

333

1982

1.83

20.18

1.3

545.26

570.23

titre

0.06

481

(3006922) Hepatitis E virus Ab [Presence] in Serum

4.92

19.71

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

446

6433

0.59

19.63

1.9

1.58

1.30

mmol/l

2.89

399

5315

(3004119) Hemoglobin [Mass/volume] in Venous blood

229

1217

2.01

19.50

5.2

2.9

111.66

130.09

g/l

26.37

223

1177

(3009261) Glucose [Presence] in Urine by Test strip

1047

8403

1.57

19.46

4.9

4.1

0.01

estimate

0.27

230

1612

(3035350) Ketones [Presence] in Urine by Test strip

1041

8351

1.57

19.33

4.8

4.1

17.89

2.63

estimate

0.84

251

1739

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

31.65

19.27

2.0

3.5

1.09

1.42

mg/l

—

(3000494) Fungus identified in Specimen by Culture

304

1807

1.82

18.37

2.1

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

241

1338

1.92

18.02

2.9

2.3

45.40

42.06

u/l

0.16

201

1078

(40760410) HLA-B [Type] by High resolution

+∞

17.73

1.0

0.0

—

(40760409) HLA-A [Type] by High resolution

+∞

17.73

1.0

0.0

—

(46236302) HLA-C [Type] by High resolution typing

+∞

17.73

1.0

0.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

195

1012

2.04

17.69

9.3

8.9

23.85

24.26

mmol/l

0.83

186

988

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

187

956

2.06

17.67

10.3

9.4

14.11

15.93

13.93

179

923

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

300

2.85

16.94

1.3

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

103

417

2.56

16.85

4.4

3.6

2.66

1.76

index

0.55

204

(3015235) Bicarbonate [Moles/volume] in Capillary blood

145

685

2.21

16.77

4.2

3.0

23.66

24.95

mmol/l

3.45

139

675

(40763590) HLA-DQ beta [Type]

+∞

16.69

1.0

0.0

—

(3013862) HLA-DP [Type]

+∞

16.69

1.0

0.0

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

27.81

16.51

2.8

1.0

29.30

16.56

u/ml

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

236

3.04

16.17

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

24.71

16.01

1.1

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1326

14757

0.63

15.93

5.5

6.6

2.45

2.54

mmol/l

2.83

1238

13552

(3027273) Bicarbonate [Moles/volume] in Venous blood

173

900

2.02

15.55

5.4

3.0

24.59

25.28

mmol/l

1.78

168

864

(40768793) Breast Pathology biopsy report

4.74

15.43

1.4

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

7.05

15.27

1.4

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

229

3.00

15.13

1.4

1.5

29.16

27.45

g/l

0.38

200

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

5.44

14.97

1.1

939.66

1725.96

miu/ml

2.41

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

177

3.23

14.44

1.7

1.9

163.48

35.22

u/ml

0.78

160

(3012501) Base excess in Blood by calculation

328

2.60

14.29

4.4

4.7

2.38

2.87

mmol/l

1.02

221

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1282

14283

0.66

14.04

7.1

7.5

40.17

40.53

mmol/mol

0.80

1209

13216

(3032352) Blasts [#/volume] in Cerebral spinal fluid

30.27

13.88

1.4

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

267

1664

1.71

13.43

5.1

3.4

—

(3014051) Protein [Presence] in Urine by Test strip

565

4205

1.50

13.34

3.9

3.2

0.06

0.05

142

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

157

3.25

13.05

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

149

784

1.98

12.95

7.8

4.5

0.87

0.86

0.10

142

745

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

214

1267

1.78

12.89

5.2

2.5

52.54

62.01

ml/min/173m2

3.71

129

536

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1295

14340

0.67

12.87

4.9

5.5

1.36

1.44

mmol/l

10.15

1205

13099

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

4.15

12.78

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

4.15

12.78

1.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1309

14455

0.67

12.69

4.9

5.6

4.30

4.44

mmol/l

4.67

1224

13307

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

158

859

1.92

12.48

7.6

4.3

1.61

0.01

151

816

(3023199) Leukocytes [#/volume] in Pleural fluid

196

2.92

12.18

1.4

1.5

944.92

1500.21

e6/l

1.20

137

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

135

702

2.00

12.14

2.8

2.1

565.82

892.63

ug/l

0.43

128

663

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

4.34

11.96

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

126

3.39

11.80

1.1

1.3

96.64

102.11

pmol/l

0.18

126

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

108

3.57

11.59

1.3

10.56

10.42

u/l

0.02

(3011397) Hemoglobin [Presence] in Urine by Test strip

527

3974

1.46

11.29

4.5

4.0

0.29

0.09

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

350

2.34

11.14

1.5

1.6

—

(3019060) Gas panel - Arterial blood

186

1109

1.75

10.90

5.4

4.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1326

14490

0.69

10.52

6.0

5.8

6.15

6.10

mmol/l

0.56

1227

13110

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

9.22

10.51

1.5

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

+∞

10.42

1.0

0.0

—

(3023183) Ammonium ion [Moles/volume] in Plasma

355

2.28

10.36

1.9

2.7

28.59

34.67

umol/l

1.73

316

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

16.13

10.35

1.8

2.4

—

(40768806) Pleura Pathology biopsy report

143

3.06

10.26

1.4

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

452

2.11

10.06

1.4

1.5

222.21

287.08

ug/g

2.46

281

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

174

2.81

9.85

1.3

1.2

—

(3035880) pH of Pleural fluid

3.66

9.55

1.1

1.3

7.44

0.06

(3052592) Norovirus Ag [Presence] in Stool

7.17

9.50

1.5

1.4

—

(3045788) Cell count panel - Pleural fluid

167

2.80

9.42

1.3

1.5

—

(3047181) Lactate [Moles/volume] in Blood

102

532

1.97

9.13

7.5

5.3

1.19

1.32

mmol/l

1.19

471

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

422

2.09

9.10

1.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

4.44

9.09

1.0

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

3.68

9.00

1.4

1.2

42.00

20.26

u/l

1.42

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.86

8.97

1.2

—

(3012441) Differential panel - Pleural fluid

166

2.75

8.96

1.4

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

185

1165

1.65

8.85

7.8

6.4

24.06

24.58

mmol/l

0.92

174

1120

(3026389) Candida sp identified in Specimen by Organism specific culture

182

2.62

8.54

1.5

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

468

1.99

8.49

3.8

2.2

114.60

130.48

g/l

8.22

377

(3028308) Erythrocytes [#/volume] in Pleural fluid

171

2.67

8.48

1.3

1.5

79714.45

82085.87

e6/l

0.01

(1761868) Lipid panel - Serum or Plasma

356

4709

0.70

8.37

3.2

3.7

—

(3022145) Colonoscopy Study observation

225

1506

1.56

8.36

1.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

+∞

8.34

1.6

0.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

8.34

1.3

0.0

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

3.45

8.23

1.4

1.1

139.36

90.07

u/l

0.91

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

241

1657

1.52

7.92

4.1

3.2

278.70

239.17

ng/l

0.58

222

1533

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

431

1.99

7.91

1.4

1.6

0.21

7.20

iu/ml

0.49

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

7.45

7.67

1.0

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

7.14

7.48

9.9

11.7

4.64

5.33

mmol/l

0.88

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

189

2.47

7.44

2.8

4.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

125

744

1.73

7.39

4.4

3.1

4.39

4.43

pmol/l

0.14

117

644

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

5.81

7.22

1.0

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1270

13762

0.75

7.20

4.6

4.7

1.35

1.27

mmol/l

3.67

1173

12425

(3032057) Clostridioides difficile [Presence] in Stool

4.51

7.18

2.0

1.9

—

(3023420) DNA double strand Ab [Units/volume] in Serum

108

627

1.77

6.98

1.7

1.8

3.20

6.66

iu/ml

2.27

147

(3049717) Cytology report of Urine Cyto stain

555

1.81

6.88

2.6

1.8

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

8.29

6.82

1.1

—

(3003181) Sodium [Moles/volume] in Urine

344

2.01

6.71

1.3

1.4

53.32

60.12

mmol/l

1.08

274

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

3.24

6.70

1.2

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

230

1623

1.48

6.65

2.3

2.2

168.87

167.45

ug/g

0.01

189

1296

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

164

2.47

6.54

1.2

3.00

8.62

u/ml

1.26

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

673

5658

1.30

6.51

2.4

2.3

151.43

237.59

u/l

3.15

646

5315

(3039000) Anion gap in Blood by calculation

348

1.99

6.50

9.5

6.2

11.10

11.21

mmol/l

0.10

314

(3018572) Chloride [Moles/volume] in Blood

348

1.99

6.50

9.5

6.2

105.48

104.99

mmol/l

0.28

314

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

137

870

1.62

6.37

2.6

2.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

11.06

6.29

1.2

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

+∞

6.25

1.3

0.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

168

2.41

6.22

1.1

1.2

1.50

2.22

u/ml

0.73

(3035947) Staphylolysin Ab [Units/volume] in Serum

3.31

6.14

1.1

—

4.00

iu/ml

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

387

1.90

6.00

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

388

1.89

5.95

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

384

1.88

5.81

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

146

2.42

5.56

4.2

3.5

13.78

11.41

index

0.77

(3029937) Albumin [Presence] in Urine by Test strip

569

4769

1.28

5.42

4.9

4.2

0.01

0.00

estimate

0.37

199

1540

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

16.07

5.41

1.4

—

(40761536) Microorganisms panel - Urine sediment

162

1112

1.50

5.37

5.4

4.1

—

(3042631) Mycobacterium sp identified in Specimen

206

2.16

5.37

2.6

3.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

11.30

5.29

1.1

296.89

217.38

nmol/l

—

(3036525) Urea [Moles/time] in 24 hour Urine

11.30

5.29

2.8

2.9

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

+∞

5.21

1.2

0.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

144

979

1.51

5.01

2.2

2.5

16.46

20.87

au/ml

—

(3045424) Erythrocytes [Presence] in Urine

123

809

1.56

4.98

2.4

2.0

0.14

1.05

estimate

0.41

238

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

4.35

4.93

4.2

2.6

0.59

0.60

mmol/l

0.17

(40768443) Skin Pathology biopsy report

615

1.63

4.84

1.4

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

2.63

4.73

1.3

1.7

16.44

14.11

umol/l

0.60

(3004451) EKG impression Narrative

121

2.42

4.65

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.82

4.55

1.0

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

228

2.00

4.52

5.4

37.2

6.46

7.57

mmol/l

2.03

193

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

6.70

4.47

1.1

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

130

889

1.50

4.43

1.2

1.4

69.05

52.31

au/ml

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

207

1554

1.37

4.25

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1515

14411

1.30

4.23

65.3

16.4

22.03

25.68

mg/l

5.36

1467

11869

(3011648) Oxygen content in Venous blood

193

2.04

4.20

1.8

1.9

8.54

10.33

1.58

193

(3041096) Erythrocytes [Presence] in Urine by Automated

493

4174

1.25

4.13

4.5

3.6

0.01

0.20

estimate

0.51

196

1312

(40768797) Stomach Pathology biopsy report

269

2115

1.32

4.07

1.3

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

704

6204

1.22

4.01

5.0

4.1

0.02

0.10

estimate

0.52

206

1357

(3046861) Legionella sp Ag [Presence] in Urine

10.03

4.01

1.0

—

(3045414) Leukocytes [Presence] in Urine

216

1649

1.35

3.99

2.5

2.0

0.07

0.02

estimate

0.35

312

(40768441) Liver Pathology biopsy report

3.04

3.96

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.83

3.96

1.1

1.2

—

(3023410) Appearance of Cerebral spinal fluid

144

2.17

3.93

1.5

1.3

—

(36660697) Celiac disease serology panel - Serum

152

1098

1.42

3.92

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

4.08

3.90

1.0

—

(3023419) Bacteria identified in Sputum by Culture

249

1.87

3.86

2.3

2.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.20

3.78

1.0

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

373

3090

1.26

3.75

1.3

1.26

1.65

u/ml

0.54

820

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.61

3.70

1.5

1.2

—

(3028433) Virus identified in Specimen by Culture

3.52

3.60

1.1

1.0

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

3.73

3.59

1.2

1.5

22.88

26.50

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

534

1.56

3.55

1.2

1.3

—

(3038515) Glucose [Moles/volume] in Venous blood

417

1.63

3.50

7.0

3.0

7.44

7.75

mmol/l

0.38

404

(3000330) Specific gravity of Urine by Test strip

129

926

1.42

3.47

4.5

3.5

1.02

ratio

0.24

119

859

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

635

1.51

3.45

1.4

1.3

—

(3008295) Osmolality of Serum or Plasma

173

1.98

3.44

1.4

1.5

276.81

273.22

mosm/kgh2o

0.27

124

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

7.02

3.36

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

122

2.15

3.26

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

149

2.03

3.26

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

332

1.68

3.25

1.4

1.3

12.55

35.00

e6/l

0.61

256

(40757373) Influenza virus identified in Isolate

3.04

3.25

1.2

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

970

8924

1.18

3.23

4.0

3.2

65.80

50.79

u/l

2.94

934

8158

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

250

0.36

3.18

1.4

1.2

1.53

1.52

g/l

—

250

(21494755) Public health laboratory ask at order entry panel

621

0.56

3.07

1.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

338

1.65

3.06

1.4

1.3

24.50

598.15

e6/l

1.10

275

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

7.52

3.05

1.5

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

2.51

3.04

1.2

1.3

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

651

0.57

2.94

1.4

1.9

3.69

3.43

mmol/l

0.50

485

(1761482) Bacteria [#/volume] in Urine by Culture

447

1.54

2.88

4.9

4.3

—

(3050794) Legionella sp Ab [Presence] in Serum

5.40

2.87

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

8.35

2.75

1.6

4.2

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

2.44

2.71

1.4

1.2

0.52

0.47

ratio

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1223

11557

1.18

2.70

72.2

20.0

15.02

13.71

124.95

1214

11357

(3003327) Ova and parasites identified in Stool by Light microscopy

401

1.54

2.61

1.6

1.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

466

1.50

2.61

1.7

1.6

16946.59

13397.78

e6/l

0.39

343

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

5.47

2.54

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

101

2.09

2.53

3.4

3.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

109

2.03

2.46

1.7

1.9

98.60

122.17

ng/l

0.56

109

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.15

2.45

3.7

4.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

904

0.67

2.43

1.9

2.1

3.87

3.45

ratio

1.20

733

(3017446) Testosterone [Moles/volume] in Serum or Plasma

133

1024

1.32

2.40

2.4

2.2

12.40

15.18

nmol/l

2.77

113

911

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

477

0.56

2.39

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

484

1.46

2.38

2.7

3.3

0.78

0.83

nmol/l

0.59

385

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

146

1.86

2.37

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

125

1.93

2.36

2.3

2.8

41.16

32.77

mg/l

0.43

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.04

2.35

1.2

1.1

—

(3017569) Oxygen content in Arterial blood

126

1.92

2.31

2.5

1.9

14.55

16.61

3.06

126

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

534

0.59

2.31

1.6

1.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

563

1.42

2.30

1.2

0.32

0.64

u/ml

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.95

2.28

1.2

1.1

—

(4195642) Thrombophilia screening test

156

1.81

2.26

1.2

—

(4268621) Lupus anticoagulant assay

120

1.93

2.26

2.2

2.3

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

3.90

2.25

1.9

1.1

102.86

110.61

—

(3036048) Francisella tularensis Ab [Titer] in Serum

3.11

2.22

1.3

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

5.57

2.21

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

5.57

2.21

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.87

2.21

4.9

1.4

—

(3026480) Teichoate Ab [Titer] in Serum

4.30

2.15

1.3

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.69

2.15

1.0

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

159

1.77

2.14

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.09

2.01

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

400

0.57

1.98

1.6

1.7

7.64

4.19

mg/l

0.45

299

(3047007) Chlamydophila sp Ab [Presence] in Serum

156

1.74

1.97

1.2

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2.09

1.96

2.4

1.5

208.30

3724.05

u/l

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.34

1.96

1.1

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.57

1.94

1.2

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

157

1.73

1.93

1.4

313.77

90.70

pmol/l

0.67

151

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

331

1.49

1.92

1.2

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

352

0.56

1.81

1.9

1.7

—

(4146454) Self-monitoring of blood glucose

221

0.45

1.81

1.4

2.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.01

1.80

1.0

1.1

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

2.18

1.78

1.5

1.3

64.57

61.24

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1017

0.75

1.75

1.2

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.34

1.74

2.8

2.1

4.17

5.28

ug/l

—

(3000963) Hemoglobin [Mass/volume] in Blood

1522

15601

0.86

1.72

86.3

24.9

117.62

134.78

g/l

251.69

1508

15356

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.85

1.71

1.0

1.2

—

(44806071) Cardiolipin IgM antibody measurement

3.85

1.71

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.85

1.71

1.0

1.2

—

(3010813) Leukocytes [#/volume] in Blood

1522

15600

0.86

1.71

85.7

24.7

6.14

6.82

e9/l

6.88

1498

15099

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1324

13702

0.88

1.71

5.8

5.3

2.11

2.02

mu/l

1.36

1257

12438

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1522

15599

0.86

1.70

86.4

25.1

35.58

40.11

182.81

1507

15347

(3026361) Erythrocytes [#/volume] in Blood

1522

15599

0.86

1.70

85.6

24.7

3.81

4.45

e12/l

251.11

1496

15099

(3035941) MCH [Entitic mass]

1522

15599

0.86

1.70

85.3

24.6

31.49

30.49

70.19

1509

15353

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1522

15597

0.86

1.69

85.4

24.6

95.47

91.74

121.73

1508

15349

(3007461) Platelets [#/volume] in Blood

1522

15597

0.86

1.69

85.8

24.7

198.69

240.40

e9/l

80.60

1499

15172

(3006270) Folate [Moles/volume] in Blood

149

1.69

1.67

1.2

341.16

350.11

nmol/l

0.07

127

(3027944) Amphetamines [Presence] in Urine

161

0.43

1.67

1.0

1.5

—

(3027008) Opiates [Presence] in Urine

162

0.43

1.67

1.0

1.5

—

(3028300) Cannabinoids [Presence] in Urine

163

0.43

1.66

1.0

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.45

1.64

1.2

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.45

1.64

1.2

1.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

213

1.56

1.63

1.3

1.4

73.40

62.75

0.94

135

(3004775) Volume in Urine collected for unspecified duration

143

1.69

1.61

1.8

2.3

585.22

614.76

0.17

(3036071) Salmonella sp Ab [Titer] in Serum

2.51

1.59

1.1

—

(3044941) Cell count panel - Synovial fluid

329

1.44

1.59

1.5

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.28

1.55

1.2

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

160

0.44

1.54

1.0

1.5

—

(3042733) HLA Ab [Presence] in Serum

2.43

1.53

2.4

3.8

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

100

1.81

1.53

2.3

2.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

161

1.62

1.53

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.86

1.50

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.13

1.44

1.0

1.3

—

(3019150) Specific gravity of Urine by Refractometry

422

3832

1.13

1.43

4.9

4.4

1.02

kg/l

0.27

320

2521

(3016879) Cocaine [Presence] in Urine

154

0.45

1.43

1.0

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

205

1.52

1.40

1.7

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

200

1724

1.18

1.39

2.9

2.5

5.85

7.82

ug/l

0.99

174

1504

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

2.42

1.39

1.3

—

7.29

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

1.92

1.33

1.2

1.1

1.04

1.14

u/l

—

(3020961) Endomysium IgA Ab [Titer] in Serum

586

1.29

1.32

1.1

—

184.18

titre

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

219

0.54

1.30

1.8

1.5

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.78

1.28

1.4

1.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

2.29

1.27

1.1

1.8

0.92

1.45

ug/l

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.29

1.27

1.0

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

106

870

1.23

1.26

1.4

1.3

73.99

256.73

u/ml

6.71

101

809

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

679

6375

1.10

1.25

5.3

4.4

2.98

2.12

ug/l

2.01

610

5728

(3034426) Prothrombin time (PT)

2.17

1.21

1.3

25.75

28.49

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.75

1.19

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.75

1.19

1.3

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

499

1.29

1.17

1.5

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

128

0.47

1.16

1.0

1.3

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

1.16

0.0

6.4

—

8.33

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

110

1.64

1.15

1.1

1.0

314.22

296.47

mg/l

0.38

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.50

1.15

1.4

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

121

1428

0.84

1.12

1.3

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.90

1.12

1.0

1.1

—

(3033799) Differential panel - Peritoneal fluid

2.00

1.12

1.9

1.8

—

(3032773) Endomysium IgG Ab [Titer] in Serum

119

1.60

1.11

1.0

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

209

1.44

1.11

1.6

1.3

14.88

8.66

u/l

0.92

171

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1520

15491

0.89

1.10

74.6

22.1

105.63

82.72

umol/l

25.01

1505

15260

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

2.26

1.10

2.0

1.1

85.29

98.58

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

113

1.60

1.05

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.74

1.02

1.1

1.3

—

(3029075) Extractable nuclear Ab panel - Serum

1.69

1.01

1.2

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

2.00

1.00

1.0

18.30

16.09

umol/l

—

(3024869) Neuronal Ab [Presence] in Serum

2.00

1.00

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

123

1.55

0.99

3.0

1.6

7.82

8.41

mmol/l

0.54

123

(3000492) Spirometry study

107

1257

0.84

0.97

1.6

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

109

1272

0.85

0.92

1.5

1.4

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

1.67

0.91

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

195

0.61

0.90

2.5

1.8

—

(4094501) Cardiovascular stress test using bicycle ergometer

460

0.76

0.88

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.79

0.88

1.3

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.72

0.86

1.4

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.82

0.86

1.0

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

408

3806

1.09

0.85

1.8

426.68

28747199.83

pmol/l

3.06

349

3096

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1170

11379

1.08

0.83

4.6

4.2

14.99

15.07

pmol/l

0.57

1106

10254

(3009508) Creatinine [Moles/volume] in Urine

606

6373

0.93

0.82

3.8

3.5

6.77

7.27

mmol/l

2.50

544

5322

(4034850) Laboratory test

544

0.79

0.82

20.7

10.5

—

(3018333) Ribosomal P Ab [Presence] in Serum

105

1.53

0.81

1.0

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

1.7

—

16.54

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

216

1.35

0.79

1.7

2.4

28.91

19.76

mg/l

0.40

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

163

0.61

0.78

2.5

1.8

—

(3006653) Thiamine [Moles/volume] in Blood

1.56

0.78

1.0

1.1

146.43

142.23

nmol/l

0.06

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

148

1.42

0.78

2.0

0.58

1.49

u/field

1.96

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1500

15233

0.92

0.75

43.3

11.1

25.93

24.97

u/l

1.11

1484

14605

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.60

0.75

2.2

2.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

1.64

0.73

1.2

—

13.20

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.58

0.71

1.4

127.33

166.31

mmol/24h

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

109

1.47

0.71

1.0

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.55

0.69

1.9

2.5

10.73

9.61

kpa

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.55

0.69

1.9

2.5

5.10

5.12

kpa

—

(3044007) Cell count panel - Peritoneal fluid

1.59

0.65

1.9

2.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

224

1.30

0.65

1.2

1.1

—

4.71

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

196

2139

0.91

0.64

12.4

7.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

120

1.42

0.64

1.0

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

544

1.18

0.62

1.5

63.11

20.92

u/ml

1.18

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.60

0.0

1.0

—

0.18

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

284

2655

1.08

0.59

1.3

27.14

38.39

iu/ml

0.71

801

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

114

1.41

0.59

1.0

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

1.48

0.57

2.0

1.8

18.99

16.04

nmol/l

0.44

(4211845) Urine protein measurement

0.57

0.56

2.8

3.7

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

212

1.28

0.55

1.9

1.3

28.93

32.22

iu/l

0.19

184

(3020191) Ethanol [Moles/volume] in Serum or Plasma

116

1.38

0.54

1.0

1.4

0.77

1.16

promille

0.42

(3025130) Human papilloma virus identified in Specimen

1.42

0.54

2.2

1.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

618

6411

0.95

0.53

4.5

4.3

26.04

7.91

mg/mmol

4.56

462

4028

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.54

0.53

1.0

1.3

—

(3022621) pH of Urine by Test strip

145

1323

1.10

0.53

3.0

5.97

6.05

0.32

117

938

(3011288) Drugs identified in Urine by Screen method Nominal

0.60

0.52

2.5

1.6

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

127

1.34

0.49

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

119

1.35

0.48

1.0

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

119

1.35

0.48

1.0

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

350

3678

0.94

0.47

3.0

0.96

0.74

ug/l

1.92

260

2549

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.40

0.45

1.0

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1.41

0.43

1.1

1.6

76.20

102.47

umol/l

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.56

0.42

1.2

1.1

151.80

201.90

pmol/l

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

425

1.16

0.42

1.3

1.50

4.90

u/ml

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

140

1.29

0.42

1.1

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

176

1.25

0.42

1.5

1.3

18347.08

158242.44

e6/l

1.95

124

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

445

1.15

0.41

1.3

1.2

83.68

42.56

u/ml

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

293

0.82

0.40

1.3

1.4

—

(3002619) Bacteria identified in Specimen by Culture

1.47

0.40

1.0

1.2

—

(3001729) Color of Synovial fluid

0.00

0.40

0.0

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.38

0.38

1.3

1.4

122.83

156.22

pmol/l

0.39

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.39

0.38

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

188

1.23

0.37

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.35

0.37

1.8

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

161

1.24

0.37

1.3

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

374

1.15

0.37

3.8

3.6

25.44

28.63

mg/l

0.38

268

(3012516) Albumin [Mass/volume] in Urine

645

6280

1.04

0.36

4.2

3.5

103.07

45.19

mg/l

5.00

510

4065

(3024263) Appearance of Synovial fluid

1.32

0.35

1.2

1.7

—

(3006462) Nitrate [Presence] in Urine

0.62

0.35

2.8

3.8

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

1.33

0.33

1.3

1.1

0.32

0.30

g/l

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.33

0.33

1.5

1.4

13.48

15.19

pmol/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

621

0.90

0.31

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

184

1.20

0.30

1.1

—

62.73

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.30

0.30

1.3

1.0

—

(3005570) Glucose [Moles/volume] in Urine

162

0.80

0.28

2.7

2.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

103

1.26

0.28

1.0

0.04

1.27

u/ml

—

(3008898) HLA-B27 [Presence]

320

0.87

0.26

1.1

—

(1002224) Polysomnography panel

465

0.90

0.24

1.0

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

341

1.12

0.23

1.8

1.9

3.34

21.05

iu/l

0.51

134

(4281824) Cell count and differential, peritoneal fluid

1.27

0.22

1.0

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.22

0.22

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.02

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

10.74

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.9

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.21

0.0

1.3

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.21

0.0

1.6

—

22.50

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

154

1.17

0.21

1.5

1.4

24.64

28.49

0.18

100

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.16

0.21

2.2

1.7

60.80

67.81

nmol/24h

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

364.77

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

219

0.87

0.20

2.2

1.3

0.90

8.82

nmol/l

0.48

209

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.20

0.0

1.1

—

6.34

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.20

0.0

1.0

—

86.86

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

212

1.13

0.19

1.4

1.3

322.62

311.21

pmol/l

0.05

180

(3023103) Potassium [Moles/volume] in Serum or Plasma

1515

15232

0.97

0.19

68.0

21.0

3.99

4.01

mmol/l

1.78

1502

14879

(3038026) Centromere Ab [Units/volume] in Serum

137

1.17

0.18

1.1

—

62.53

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

762

1.05

0.14

1.1

1.2

110.43

116.54

u/ml

0.05

299

(3019550) Sodium [Moles/volume] in Serum or Plasma

1514

15203

0.98

0.13

62.3

20.8

138.84

139.78

mmol/l

37.88

1501

14873

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

106

0.85

0.13

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1.16

0.11

1.0

1.1

0.08

1.21

u/ml

—

(4024509) Urine culture

890

1.04

0.10

2.7

2.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.06

0.09

3.0

1.4

10.94

9.16

ug/l

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

1.09

0.09

1.0

1.2

33.17

29.45

umol/l

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

512

5169

0.99

0.08

4.2

4.1

22.74

24.33

1.46

275

2622

(4015189) Microbial culture of sputum

0.83

0.08

1.8

2.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

245

0.94

0.07

1.7

—

(44813793) Dust mix specific IgE antibody measurement

0.84

0.07

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.05

0.07

1.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

247

2502

0.99

0.06

1.3

6.96

12.80

u/ml

0.77

928

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

208

2105

0.99

0.05

4.3

5.5

33.18

33.47

0.12

157

1345

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

127

1291

0.98

0.05

1.7

1.48

1.60

1.36

108

1086

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1.10

0.04

1.0

1.1

0.36

3.19

u/ml

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1395

13974

0.99

0.03

53.0

16.2

67.33

73.54

ml/min/173m2

19.32

1338

12962

(44806420) Estimation of glomerular filtration rate

131

1.07

0.03

2.8

2.7

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

189

0.95

0.03

2.1

1.3

—

nmol/l

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

461

1.02

0.02

2.4

2.2

81.31

84.88

ug/min

0.04

274

(3006442) Creatine [Moles/volume] in Serum or Plasma

101

0.99

0.00

1.6

1.7

82.40

90.65

umol/l

—

101

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

159

1.01

0.00

1.1

0.16

1.13

u/ml

—

(3004616) Nuclear Ab [Presence] in Serum

211

1.00

0.00

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

527

1.01

0.00

1.5

0.40

0.36

mg/l

0.12

222

(3012403) Metanephrines [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.00

0.0

6.4

—

10.80

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.2

—

29.80

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

373.00

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

284.40

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.94

0.00

1.2

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.0

3.2

—

44.00

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.91

0.00

1.6

1.3

31.91

18.74

umol/l

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.2

—

7.47

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.01

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

-0.00

0.0

1.5

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

-0.00

0.0

9.7

—

105.00

—

(3022689) Creatine [Moles/volume] in Urine

1.00

-0.00

3.6

1.4

7.02

7.61

mmol/l

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

63.31

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_MULT_MYELOMA_WIDE – Multiple myeloma, including Hilmo

GWS hits: 2

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Multiple myeloma, including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Multiple myeloma, including Hilmo (C3_MULT_MYELOMA_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints